How many patents does
Fukuoka University have?
patents
296
families
57
granted
71
applications
225
JP
93
US
55
WO
51
EP
42
CN
29
KR
7
RoW
19
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Fukuoka University
Top ten assignees appearing on patents
2009 - 2018
| fuji machine manufacturing company | 12 |
| chugai pharmaceutical | 11 |
| mayatec | 11 |
| sonocore | 10 |
| wan station company | 9 |
| zuken | 7 |
| hioki ee corporation | 6 |
| keirex technology | 5 |
| fujifilm | 4 |
| lsi medience corporation | 4 |
2018
| sonocore | 10 |
| lsi medience corporation | 1 |
Fukuoka University
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| bubble production method | 23 | 2015 |
| anti-apoptosis or anti-necrosis induction method | 14 | 2011 |
| agents for suppressing damage to transplanted islets after islet transplantation | 14 | 2005 |
| rotaxane compound and antitumor agent | 12 | 2008 |
| dispersing agent, dispersion and method for adjusting viscosity of dispersion | 11 | 2011 |
| method for detecting disseminated intravascular coagulation or infectious disseminated i… 🛈 | 10 | 2012 |
| phosphine compound, process for producing the same, and peroxide scavenger using the same | 9 | 2008 |
| inhibitor of ischemic disorders | 9 | 2007 |
| ultrasonic drug delivery system for dental use and ultrasonic drug delivery method for d… 🛈 | 9 | 2009 |
| therapeutic agent for blood-brain barrier disruption syndrome | 9 | 2010 |